Literature DB >> 16718748

Reassessment of functional dyspepsia: a topic review.

Andrew Seng Boon Chua1.   

Abstract

Dyspepsia itself is not a diagnosis but stands for a constellation of symptoms referable to the upper gastrointestinal tract. It consists of a variable combination of symptoms including abdominal pain or discomfort, postprandial fullness, abdominal bloating, early satiety, nausea, vomiting, heartburn and acid regurgitation. Patients with heartburn and acid regurgitation invariably have gastroesophageal reflux disease and should be distinguished from those with dyspepsia. There is a substantial group of patients who do not have a definite structural or biochemical cause for their symptoms and are considered to be suffering from functional dyspepsia (FD). Gastrointestinal motor abnormalities, altered visceral sensation, dysfunctional central nervous system-enteral nervous system (CNS-ENS) integration and psychosocial factors have all being identified as important pathophysiological correlates. It can be considered as a biopsychosocial disorder with dysregulation of the brain-gut axis being central in origin of disease. FD can be categorized into different subgroups based on the predominant single symptom identified by the patient. This subgroup classification can assist us in deciding the appropriate symptomatic treatment for the patient.

Entities:  

Mesh:

Year:  2006        PMID: 16718748      PMCID: PMC4130970          DOI: 10.3748/wjg.v12.i17.2656

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Drug treatment of functional dyspepsia.

Authors:  Klaus Mönkemüller; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 2.  Cholecystokinin hyperresponsiveness in functional dyspepsia.

Authors:  A S B Chua; P W N Keeling
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 3.  Central serotonergic and noradrenergic receptors in functional dyspepsia.

Authors:  S O'Mahony; T G Dinan; P W Keeling; A S B Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 4.  Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis.

Authors:  John Keohane; Eamonn M M Quigley
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 5.  Role of Helicobacter pylori in functional dyspepsia.

Authors:  Colm O'Morain
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 6.  Subtypes of functional dyspepsia.

Authors:  Georgina Baker; Robert J Fraser; Graeme Young
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 7.  Functional dyspepsia: are psychosocial factors of relevance?

Authors:  Sandra Barry; Timothy G Dinan
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 8.  Epidemiology of functional dyspepsia: a global perspective.

Authors:  Sanjiv Mahadeva; Khean-Lee Goh
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 9.  Functional dyspepsia and irritable bowel syndrome, are they different entities and does it matter?

Authors:  Kok-Ann Gwee; Andrew Seng Boon Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

  9 in total
  5 in total

Review 1.  Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms?

Authors:  S E Kim; L Chang
Journal:  Neurogastroenterol Motil       Date:  2012-08-02       Impact factor: 3.598

2.  Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Muhammed Majeed; Shaheen Majeed; Kalyanam Nagabhushanam; Sivakumar Arumugam; Anurag Pande; Mahesh Paschapur; Furqan Ali
Journal:  J Med Food       Date:  2018-08-29       Impact factor: 2.786

3.  Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study.

Authors:  Linda E Bröker; Gerard J B Hurenkamp; Gerben ter Riet; François G Schellevis; Hans G Grundmeijer; Henk C van Weert
Journal:  BMC Fam Pract       Date:  2009-09-09       Impact factor: 2.497

4.  Investigating functional dyspepsia in Asia.

Authors:  Yeong Yeh Lee; Andrew Seng Boon Chua
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

5.  Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia.

Authors:  R Lozano; Mg Peralta Concha; A Montealegre; L de Leon; J Ortiz Villalba; Ho Lee Esteban; M Cromeyer; Ja Rivas García; A Brossa; G Lluberes; E Izquierdo Sandí; H Burgos Quirós
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.